Transcription of Good Manufacturing Practice (GMP) -What
1 Good Manufacturing Practice (GMP) What it means to you!Lee WongAims and ObjectiveszBrief overview of GMP Laws & Principles of GMPzDiscuss the implications of GMP on Blood Establishments and Hospital Blood at the links between GMP & the BSQRzDiscuss what we need to do to comply with GMPI ntroductionzGood Manufacturing Practice (GMP) ensures that quality is built into the organisation and processes involved in manufacturezGMP covers all aspects of manufacture including collection, transportation, processing, storage, quality control and delivery of the finished the whyz1937.
2 USA .. Sulphanilamide tragedy ..107 children ..Europe .. Thalidomide ..foetal abnormalitiesz1986 ..USA ..Conneticut Blood BankzPoor computer controlszBlood rejected by the laboratory ..(due to HIV)zComputer failed to stop dispatch /use of rejected bloodzDespite increasing public demand for no risk products ..errors continue!GMP that part of Quality Assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their use. GMP is an integral part of Quality AssuranceQuality AssuranceGMPQ ualityControlBasic Requirements of GMPzAll Manufacturing processes are clearly defined, systematically reviewed, and shown to be capable of consistently Manufacturing medicinal products of the required quality and complying with steps of the process and significant changes to the process are validatedEU Blood Directive.
3 2002/98/ECzIn November 2005 changes in law came into force, that give powers to control Blood Establishments and Blood controls are based on a long established method for controlling medicines GMP means to us ..zBSQR Standards 2005 mean that we are now audited as a Blood Establishments must implement:zEffective quality systems, systematic approach to compliancezGood Manufacturing Practice GMPWhat GMP means to standards for such a system will by the blood establishmentszEnforced by the competent authority Medicines Healthcare & Regulatory AgencyRegulatory ExpectationszRequirements are now defined in statutezBlood Establishments are inspectablezNon-compliance is subject to legal sanctionzStrict product liability applieszKey to regulatory expectations arezArrangements made for quality assurancezOperation of defensible GMPzClearly defined individual responsibilitiesMHRA
4 Inspection ObservationszCritical :has produced a product harmful to a person, leads to a significant risk of harming a :has produced or may produce a product which does not comply with GMP, indicates a major deviation from : a combination of several other deficiencies, none of which on their own may be major, but which may together represent a major deficiency and should be explained and reported as such. A departure from GMP means to Directive 2002/98/EC states blood establishmentsshould establish and maintain quality systems involving all activities that determine the quality policy objectives & responsibilities.
5 Taking into account the principles of good Manufacturing Practice Article 6 of 2002/98/EC that Blood Banks must comply with the following Articles of the Directive: Article 7, 10, 11(1), 12(1), 14, 15, 22 & 11(1) states member states shall take all necessary measures to ensure that each blood establishment establishes & maintains a quality system based on the principles of good Practice GMP Orange GuidezQuality ManagementzPersonnelzPremises and EquipmentzDocumentationzProduction/Proce sseszQuality ControlzContract ManufacturezComplaints & Product RecallzSelf on:Computer systemsValidation and qualificationGMP & BSQRzBSQR Article 10 Qualified personnel with appropriate trainingzGMP Guide Chapter 2.
6 Personnel- Qualified personnel with appropriate trainingzBSQR Article 11(1) Quality Management SystemzGMP Guide Chapter 1: Quality Management comprehensive QA system incorporating GMP & QCGMP & BSQRzBSQR Article 12(1) Full documentation including operating procedures, guidelines, training reporting forms Article 14 Traceability involving all documentationzGMP Guide Chapter 4: Documentation- full documentation and written procedures for all activities performed which may directly or indirectly affect the productGMP & BSQRzBSQR Article 15: Adverse Incident Reporting all serious adverse events and reactions are reportable to SABREzGMP Guide - Chapter 8:Complaints and Product Recall written instructions for the recall of all defective products & Chapter 9: Self Inspection-provision of internal audits to achieve quality improvementsGMP & BSQRzBSQR Article 22: Storage, transport and distribution all blood and blood products are stored appropriately and storage conditions monitoredzGMP Guide - Chapter 3.
7 Premises and Equipment ensure premises and equipment is designed and constructed to ensure products are safe for Management SystemzSatisfy regulatory/accreditation requirementsz owned and understood by the workforcezIs an integral part of how everyoneworkszGMP focusedzEnsures the delivery of high quality products and/or serviceszCommitment from everyone is vitalQuality Management System for BSQRzQuality Incident Reports zSelf InspectionzTechnical AgreementszComplaintszComponent RecallzReceipt & storage of componentszTraceabilityzAdverse reactions & eventsChapter 1 GMPC hapter 9 GMPC hapter 8 GMPC hapter 5 GMPC hapter 4 GMPC hapter 8 GMPC hapter 8 GMPC hapter 7 GMPQ uality Management System for BSQRzQuality manual incorporating specifications agreed with MHRAzAccess to Quality Manager with designated responsibilityzStaff are provided with timely.
8 Relevant and regularly updated trainingzDocument control systemzTraceability requirements are metzRegular performance reviews of QMSC hapter 1 - GMPC hapter 4 - GMPC hapter 2 - GMPC hapter 4 - GMPC hapter 1 - GMPC hapter 1 - GMPQ uality Management System for BSQRzSops for the storage, distribution & transport of blood/blood components within & outside hospitalzSOPs covering temperature controlled storage, its monitoring and management of the cold chain zStandard procedures for the validation & calibration of processes & equipmentzSOPs for the notification of serious adverse events & reactionszSOPs that allow the accurate, efficient & verifiable withdrawal of blood/blood components if notified of a quality issueChapter 5 - GMPC hapter 5 - GMPC hapter 5 - GMPC hapter 5 - GMPC hapter 5 - GMP2.
9 Personnel - GMPzThere are competent and appropriately qualified personnel in sufficient numbers to ensure service responsibilities of all staff should be clearly understood and personnel receive initial and continuing training relevant to their staff who have appropriate training are authorisedto carry out that - GMPzTraining should be structured and continuous. Training records based on SOPs are a good means of evidencing that staff are able to perform Assessments can also be used to assess procedural Occupational Standards HCS BT1: Determine major blood groupszKSF Dimension & Level :Health and wellbeing HWB8: Biomedical investigation and interventionLevel 2: Undertake and report on routine biomedical investigations and/or criteriaa) Select the correct techniques and reagents and ) Prepare the blood grouping system for use c) Avoid cross contamination through application of correct procedures.
10 D) Determine ABO & Rh and other major blood groups by use of selected techniquese) Accurately document and record resultsf) Recognise instrument or system errors in ) Interpret results with reference to controls h) Identify anomalous results and investigatei) Identify samples requiring further or additional testing j) Validate current grouping results with reference to previous test resultsk) Place sample and associated records in the location and storage conditions appropriate for next stage of processingl) Minimise clinical impact of process delays by analysing with suitable degree of urgency for clinical needKnowledge & Understanding1.